Forbes Alexandria — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Forbes Alexandria has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.81M.

Profile

Alexandria Forbes is the President and CEO of MeiraGTx Holdings plc, a clinical-stage gene therapy company focused on treating disorders of the eye, salivary gland, and central nervous system. She has significant experience in the biotechnology sector, leading the company in its innovative gene therapy initiatives.

Board memberships

• MeiraGTx Holdings plc

Awards & honors

• Leading MeiraGTx in gene therapy advancements
• Expanding the company's clinical pipeline
• Driving strategic partnerships

Recent Transactions

Companies — Last 90 Days

• MeiraGTx Holdings plc (MGTX) — 2 filings, last 2026-06-30

Frequently Asked Questions

Who is Forbes Alexandria?

Alexandria Forbes is the President and CEO of MeiraGTx Holdings plc, a clinical-stage gene therapy company focused on treating disorders of the eye, salivary gland, and central nervous system. She has significant experience in the biotechnology sector, leading the company in its innovative gene therapy initiatives.…

How many SEC Form 4 filings has Forbes Alexandria submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Forbes Alexandria been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.81M) across all tracked filings.

Where can I see all of Forbes Alexandria's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week